Drug Targeting and Design

Special Issues

Following special issues within this section are currently open for submissions:

• Advances in Drug Delivery Systems for Transmucosal Routes Applied in the Treatment of Infectious and Chronic Degenerative Diseases (Deadline: 15 November 2024)
• Peptide–Drug Conjugates for Targeted Delivery (Deadline: 20 November 2024)
• Computer-Aided Development: Recent Advances and Expectations (Deadline: 20 November 2024)
• Ultrasound Assisted in Tumor Immunotherapy (Deadline: 20 November 2024)
• Novel Therapies Based on Autophagy Modulation: Targets, Mechanisms, and Delivery Approaches (Deadline: 20 November 2024)
• Metallodrugs in Cancer Therapy: The Newest Candidates in the Field, 2nd Edition (Deadline: 20 November 2024)
• Advances in Antiparasitic Agents (Deadline: 25 November 2024)
• Natural Pharmaceuticals Focused on Anti-inflammatory Activities (Deadline: 30 November 2024)
• Cutting-Edge Liposome Innovations for Precision Delivery and Cancer Treatment (Deadline: 30 November 2024)
• Novel Therapeutic Approaches for the Treatment of Neurodegenerative Diseases (Deadline: 30 November 2024)
• Novel Drugs, Targets and Therapies Against Infectious Diseases (Deadline: 30 November 2024)
• New Platform for Tuberculosis Treatment (Deadline: 30 November 2024)
• Applications of Stable Nuclide and Radionuclides in the Area of Pharmacokinetic Process Control and Targeted Drug Therapy (Deadline: 30 November 2024)
• Current and Future Cancer Chemoprevention Strategies, 2nd Edition (Deadline: 10 December 2024)
• Pharmaceutical Applications of Plant Extracts, 2nd Edition (Deadline: 10 December 2024)
• Next-Generation Antibody-Drug Conjugates (ADCs) (Deadline: 20 December 2024)
• Pharmaceutical Applications of Metal Complexes and Derived Materials (Deadline: 20 December 2024)
• Studies on the Cytotoxicity and Antimicrobial Effects of Synthetic and Natural Compounds (Deadline: 20 December 2024)
• State of the Art of Membrane Active Peptides, 2nd Edition (Deadline: 30 December 2024)
• Alternative Model-Based Translational Drug Development (Deadline: 31 December 2024)
• Prodrugs and Molecular Hybrids as Innovative Strategies in Medicinal Chemistry (Deadline: 31 December 2024)
• Combination Therapy Approaches for Cancer Treatment (Deadline: 31 December 2024)
• Theranostic Radiopharmaceuticals: Current Status and Perspectives (Deadline: 31 December 2024)
• Where Are We Now and Where Is Antimicrobial Therapy Headed? (Deadline: 31 December 2024)
• Novel Pharmaceuticals Development and Delivery Systems for the Treatment of Parasitic Diseases, 2nd Edition (Deadline: 31 December 2024)
• Emerging Pharmaceutical Strategies against Infectious Diseases (Deadline: 31 December 2024)
• In Vitro and In Vivo Studies of Natural Antimicrobial Peptides as Promising Therapeutic Agents (Deadline: 31 December 2024)
• Recent Advances in Natural Product Drugs, 2nd Edition (Deadline: 31 December 2024)
• Drug Targeting for CNS Disease, 2nd Edition (Deadline: 10 January 2025)
• Drug Repurposing and Delivery Systems for Immunotherapy (Deadline: 20 January 2025)
• Application Prospect of Hydrogels in the Treatment of Osteochondral Lesions (Deadline: 20 January 2025)
• Targeting Protein Aggregation and Degradation in Age-Related Diseases (Deadline: 20 January 2025)
• Multi-Target Ligands Design and Targeted Drug Delivery (Deadline: 31 January 2025)
• Targeted Immune Modulation Strategies for Cancer, Infectious and Autoimmune Diseases (Deadline: 31 January 2025)
• Serpins: Therapeutic Targets for Various Diseases (Deadline: 31 January 2025)
• Research on the Design of New Metal-Based Antitumor Drugs (Deadline: 31 January 2025)
• Small-Molecule Inhibitors for Novel Therapeutics (Deadline: 31 January 2025)
• Advances in Antileishmania Drug Agent (Deadline: 10 February 2025)
• Biomaterials and Agents: Pharmaceutical and Biomedical Applications in Dental Research, 2nd Edition (Deadline: 10 February 2025)
• Progress in Photoactive Biomaterial-Based Synergistic Combination Phototherapy (Deadline: 20 February 2025)
• Plant Extracts and Their Biomedical Applications (Deadline: 20 February 2025)
• Smart Radiotherapy Biomaterials for Cancer Therapy and Imaging (Deadline: 20 February 2025)
• Research on Radiotracers and Novel Radiopharmaceuticals for Cancer Therapy and Diagnosis (Deadline: 20 February 2025)
• Antiviral and Antibacterial: Focus on Novel Therapeutic Agents and Drug Delivery Systems (Deadline: 28 February 2025)
• Membrane Transport and Drug Permeation (Deadline: 28 February 2025)
• Research on Porphyrin Compounds Used in Photodynamic Anticancer and Antimicrobial Therapy (Deadline: 28 February 2025)
• Advanced Nanopharmaceuticals for Anticancer Therapy (Deadline: 28 February 2025)
• New Insights into Targeted Therapy of Solid Tumors with Polymeric Nanoparticles (Deadline: 28 February 2025)
• Natural Products in Photodynamic Therapy (Deadline: 20 March 2025)
• Recent Advances in Therapeutic Strategies for the Treatment of Pediatric Diseases (Deadline: 31 March 2025)
• Natural and Synthetic Compounds in Pharmaceutical Formulations and Drug Delivery Systems (Deadline: 31 March 2025)
• Recent Advances in Hepatic-Targeted Drug Delivery Systems (Deadline: 31 March 2025)
• Brain Tumors Treatment: Current and Future Challenges from Drug Formulations to Delivery Methods (Deadline: 31 March 2025)
• Therapeutic Approaches for Wound-Associated Skin Diseases (Deadline: 31 March 2025)
• Novel Approaches in the Search for Active Compounds in Drug Discovery and Development (Deadline: 1 April 2025)
• Natural Products for Antimicrobial and Drug Delivery: A Look into the Future (Deadline: 10 April 2025)
• Natural Products and Extracts Important for Skin Health and Diseases (Deadline: 10 April 2025)
• Innovative Drug Delivery Systems for Enhanced Therapeutic Efficacy in Cancers, Liver Disease and Psoriasis (Deadline: 20 April 2025)
• Novel In Silico Supported Approaches for the Development and Delivery of Drugs for Antimicrobial Therapy and Neurodegenerative Diseases (Deadline: 25 April 2025)
• Skin Care Products for Healthy and Diseased Skin (Deadline: 30 April 2025)
• Self-Assembled Amphiphilic Copolymers in Drug Delivery, 2nd Edition (Deadline: 30 April 2025)
• Nanosystems and Antibody/Peptide Modified Drugs for Cancer Treatment (Deadline: 30 April 2025)
• Kinase Inhibitor for Cancer Therapy, 2nd Edition (Deadline: 30 April 2025)
• Advances in Drug Delivery Systems for Leishmaniasis Therapy (Deadline: 30 April 2025)
• Recent Advances in Drug Formulation for Antiviral Therapy (Deadline: 30 April 2025)
• The State-of-the-art in Improving the Antitumor Efficacy of Platinum Drugs (Deadline: 20 May 2025)
• The Role of Free Radicals and Antioxidants in Drug Activation and Effectiveness in Different Biological Systems (Deadline: 20 October 2025)